Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia

NCT01414803 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Lipid modification
DRUG: Lipid modification

Sponsor

Yonsei University